Pages that link to "Q45207982"

The following pages link to Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders (Q45207982):

Displaying 42 items.

• Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice (Q24622196) (← links)
• Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease (Q24684559) (← links)
• The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment (Q26827320) (← links)
• Oxidative stress in aging: advances in proteomic approaches (Q27025199) (← links)
• Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease (Q30394816) (← links)
• Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease (Q30494084) (← links)
• Changes in protein expression in the rat medial vestibular nuclei during vestibular compensation (Q33249153) (← links)
• Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis (Q33639885) (← links)
• Proteomic identification of carbonylated proteins and their oxidation sites (Q34118916) (← links)
• Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments (Q34310402) (← links)
• Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression. (Q34429308) (← links)
• Reactive oxygen species in the regulation of synaptic plasticity and memory (Q34805998) (← links)
• Animal models in the drug discovery pipeline for Alzheimer's disease (Q35589962) (← links)
• Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment (Q36076365) (← links)
• Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities (Q36521858) (← links)
• Redox proteomics in some age-related neurodegenerative disorders or models thereof (Q36525171) (← links)
• Proteomic approach to aging research (Q36787263) (← links)
• The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview (Q36867029) (← links)
• Proteomics in animal models of Alzheimer's and Parkinson's diseases (Q37071539) (← links)
• Insulin, insulin-like growth factors and incretins: neural homeostatic regulators and treatment opportunities (Q37165497) (← links)
• The senescence-accelerated mouse (SAM): a higher oxidative stress and age-dependent degenerative diseases model. (Q37238415) (← links)
• The use of proteomic techniques to explore the holistic effects of nutrients in vivo (Q37350028) (← links)
• Clinical proteomics in neurodegenerative diseases (Q37817086) (← links)
• Proteomics‐based investigations of animal models of disease (Q37817232) (← links)
• Redox proteomics studies of in vivo amyloid beta‐peptide animal models of Alzheimer's disease: Insight into the role of oxidative stress (Q37817235) (← links)
• Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier (Q37971834) (← links)
• Protein carbonylation: proteomics, specificity and relevance to aging. (Q38151609) (← links)
• Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants. (Q38253060) (← links)
• Development of alpha-lipoic acid encapsulated chitosan monodispersed particles using an electrospray system: synthesis, characterisations and anti-inflammatory evaluations (Q39008605) (← links)
• Expressive proteomics profile changes of injured human brain cortex due to acute brain trauma (Q39953574) (← links)
• Transcriptome analysis in calorie-restricted rats implicates epigenetic and post-translational mechanisms in neuroprotection and aging. (Q40181227) (← links)
• Effects of Lipoic Acid on High-Fat Diet-Induced Alteration of Synaptic Plasticity and Brain Glucose Metabolism: A PET/CT and 13C-NMR Study. (Q41019705) (← links)
• Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. (Q41121746) (← links)
• Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease (Q42280312) (← links)
• Lipoic acid inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after pilocarpine-induced seizures (Q42825910) (← links)
• Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration. (Q47446148) (← links)
• Chronic pretreatment with acetyl-L-carnitine and ±DL-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function (Q48277918) (← links)
• When nature's robots go rogue: exploring protein homeostasis dysfunction and the implications for understanding human aging disease pathologies (Q51763128) (← links)
• Can we improve care for patients with dementia? (Q53321175) (← links)
• Aberrant Expression Profiles of lncRNAs and Their Associated Nearby Coding Genes in the Hippocampus of the SAMP8 Mouse Model with AD (Q90314502) (← links)
• BRAIN LIPID PEROXIDATION AND ALZHEIMER DISEASE: SYNERGY BETWEEN THE BUTTERFIELD AND MATTSON LABORATORIES (Q90601707) (← links)
• Current Awareness on Comparative and Functional Genomics (Q94101727) (← links)